Novartis

NVS · NYSE · USD

141,00 $Variación respecto al cierre anterior: −0,04 %Variación absoluta: −0,05 $

Cierre · 2 de octubre de 2026

En resumen

Crecimiento de los ingresos
+9,57 %
2025 frente a 2024
Crecimiento del beneficio neto
+17,11 %
2025 frente a 2024
Margen neto
24,7 %
2024: 23,1 %

Datos financieros

Importes en millones de USD; valores por acción en USD; acciones en millones.

Balance · Trimestral
PartidaT2 2026T1 2026T4 2025T3 2025T2 2025T1 2025T4 2024T3 2024T2 2024T1 2024T4 2023T3 2023
Activo total122.033118.532110.949107.289104.39599.941102.246103.52497.50594.33499.945112.697
Activo corriente27.35126.60730.46028.19825.93925.10829.70431.26425.69326.44730.48145.660
Efectivo y equivalentes7.6166.87711.4359.5566.6567.06611.45913.6097.9039.46913.39312.405
Inversiones a corto plazo2,015,098,011276,071,01.892242528234680411
Cuentas por cobrar9.8549.60210.8338.9849.1768.7259.1318.1508.4808.2519.2477.099
Existencias6.2206.2866.2696.4216.3075.8295.7235.9395.7475.7435.9135.610
Inmovilizado material neto12.26712.23812.35211.99111.82611.08710.87311.20110.62210.54210.92410.344
Fondo de comercio26.76726.81925.56725.55125.55324.96524.75624.93025.23423.06323.34123.416
Otros activos intangibles42.07440.20929.41129.03729.24027.47626.91527.90227.77526.27226.87926.418
Inversiones a largo plazo3711.6561.0911.4071.4001.4091.1281.5451.6252.1021.8271.530
Pasivo corriente31.74831.37427.27832.00031.71431.61928.69228.13227.61229.28826.39048.393
Proveedores4.2584.3224.4564.5554.5064.2614.5724.0874.1464.0624.9263.870
Deuda a largo plazo37.48937.44727.93522.59822.47021.66621.36623.75019.66317.19118.43618.068
Deuda total49.01446.99830.73032.02232.63731.27026.66832.15928.98727.284——
Pasivo total80.08779.60564.40062.53762.34161.48958.12060.08355.60354.57853.19574.452
Patrimonio neto (incl. minoritarios)41.94638.92746.54944.75242.05438.45244.12643.44141.90239.75646.75038.245
Reservas39.64937.25244.72043.51041.52739.83946.56146.29245.83643.83449.64942.333
Intereses minoritarios40441541942269,083,080,012416981,083,081,0